Back to competency map
Clinical competency
Medical contraindication screening
Recognizes medical factors that may increase risk during inhaled 5-MeO-DMT administration. Medical clearance is required before dosing.
Primary clinical guidelineModern clinical
Looking for something specific? Ask Blossom
Guidelines
1
Courses
0
Providers
0
Protocols
2
Classification
Competency categories
Care stages
Roles
Protocol families
Source quality
Protocol paper
Linked sources
The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.
Linked guidelines (1)
A Phase 1/2 Trial of Vaporized 5-MeO-DMT (GH001) in Treatment-Resistant Depression
5-MeO-DMTEvidence score: 90
Unlock every linked source
See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.